MOTHAFFAR RIMAWI to Amenorrhea
This is a "connection" page, showing publications MOTHAFFAR RIMAWI has written about Amenorrhea.
Connection Strength
0.047
-
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial). Breast Cancer Res Treat. 2021 Aug; 189(1):103-110.
Score: 0.047